Author

André Schultz

Ruhr University BochumPrimary ORCID profile (0000-0002-2909-3154 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

André SchultziD1 paper · The University of Texas MD Anderson Cancer Center

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Julia Elisabeth BandowiD· 2 shared André HaaseiD· 1 shared Anne-Kathrin Klebl· 1 shared Beate Lungerich· 1 shared Bert KlebliD· 1 shared Björn B. Burckhardt· 1 shared Carsten Degenhart· 1 shared Finn Dressler· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Julia Elisabeth BandowORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

3-Hydroxypropanamidines: from antiplasmodial leads to a novel antibacterial scaffold

Lara-Sophie Kaufmann, André Schultz, Noemi Wladarz, Tanja Gangnus, Beate Lungerich, Tanja C. Knaab, André Haase, Lea Joswig, Finn Dressler, Pascal Dietze, Ralf A. Benndorf, Björn B. Burckhardt, Thomas Kurz, Julia Elisabeth Bandow

This study evaluates the antibacterial activity and properties of three 3-hydroxypropanamidines against Gram-positive and Gram-negative bacteria.

bioRxiv · Sep 21, 2026 · PreprintMicrobiology

Enabling antibiotic research: towards selective peptide deformylase inhibitors

Nathalie Bachmann, André Schultz, Manuela Zouatom, Tianyi Zhou, Carsten Degenhart, Uwe Koch, Sina Schäkermann, Julia Hüning, Sascha Heinrich, Michael Dal Molin, Mia‐Lisa Zischinsky, Sylvain Tourel, Anne-Kathrin Klebl, Jan Rybniker, Bert Klebl, , Julia Elisabeth Bandow

This study identifies two selective peptide deformylase inhibitors with antibacterial activity and low cytotoxicity, validated through in vitro and in vivo assays.

bioRxiv · Sep 18, 2025 · PreprintMicrobiology